Vanguard Capital Management’s Cabaletta Bio CABA Stock Holding History
Bought
Maintained
Sold
Other funds holding CABA
Vanguard Capital Management's CABA Position: Q3 2026 in Review
Vanguard Capital Management reduced its Cabaletta Bio (CABA) stake by 1.1% in Q3 2026, selling an estimated $232K and leaving 7,144,758 shares worth $13.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2592.
Vanguard Capital Management first reported a position in CABA in Q1 2026 and has held it in 3 quarters since. The position peaked at $22.5M in Q2 2026. 163 funds tracked by Wall St. Rank hold CABA as of Q3 2026.
- Vanguard Capital Management held 7,144,758 shares of Cabaletta Bio worth $13.7M as of Q3 2026.
- Vanguard Capital Management sold 82,260 Cabaletta Bio shares in Q3 2026, an estimated $232K.
- Cabaletta Bio made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2592 holding.
- Vanguard Capital Management first reported a position in Cabaletta Bio in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Cabaletta Bio position peaked at $22.5M in Q2 2026.
- 163 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.